Unia Europejska - islandzki - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - Æxlishemjandi lyf - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Unia Europejska - islandzki - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidone - geðklofa - psycholeptics - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 50 mg

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 37,5 mg

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 25 mg

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - mixtúra, lausn - 1 mg/ml

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - filmuhúðuð tafla - 1 mg

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - risperidonum inn - filmuhúðuð tafla - 2 mg

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - risperidonum inn - filmuhúðuð tafla - 1 mg

Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - apomorphin hýdróklóríð - innrennslislyf, lausn - 5 mg/ml